How to Sell a Veterinary Practice in Asia Pacific
How to sell a veterinary practice in APAC: EBITDA multiples, who the buyers are, and how confidential AI matching connects vet practice owners with qualified investors.
Veterinary practices across Asia Pacific have become one of the most sought-after small business acquisition targets in the region. PE-backed consolidators, corporate vet groups, and Japanese and Korean pet industry strategics are actively acquiring, driven by structural tailwinds: accelerating pet ownership across APAC, chronic undersupply of specialist veterinarians, and a proven PE roll-up model demonstrated in Australia and increasingly replicating across Southeast Asia and East Asia.
Most veterinary practice owners — GPs, dental vets, specialists, emergency clinicians — built their practices around clinical excellence, not M&A planning. This guide covers who the buyers are, what they pay, and how to run a confidential exit process in APAC’s veterinary sector.
Amafi is a confidential M&A matching marketplace for veterinary practice owners. Your practice is matched privately to qualified buyers — PE consolidators, corporate vet groups, and family offices — without a public listing. See who would buy your practice →
Who Buys Veterinary Practices in APAC
Buyer demand for APAC veterinary practices comes from several distinct pools, each with different criteria:
PE-backed consolidators — groups such as VetPartners (operating in Australia and expanding in Asia), National Veterinary Care Australia (NVC), and Greencross Vets are building regional vet networks through acquisition. Mars Veterinary Health (now the world’s largest vet care provider) is active across APAC. These buyers target practices with EBITDA of AUD/SGD $500K+ and a multi-vet structure that reduces single-practitioner dependency. They pay the highest multiples and move quickly once due diligence is satisfied.
Corporate vet groups — regionally established groups seeking geographic or specialist expansion are active acquirers of practices that extend their service footprint. They value patient relationships, geographic position, referral network integration, and real estate optionality.
Japanese and Korean pet industry strategics — as pet ownership rates accelerate in Japan and South Korea (Japan: 16% household dog ownership and rising, South Korea: 24% and growing), domestic vet groups and pet retail chains are acquiring clinical capabilities. These buyers typically target practices in their home market or in APAC hubs (Singapore, Australia) for capability acquisition.
Family offices and private capital — Singapore, Hong Kong, and Australian family offices with essential services investment mandates are increasing veterinary allocations, particularly in clinics with strong cash flows and real estate ownership. Deal sizes typically fall in the $5M–$30M range.
Independent vets and practice groups — regional expansion by established practices is common for general practices below the PE acquisition threshold. A single-vet rural clinic may be acquired by a multi-vet suburban group rather than a corporate buyer.
EBITDA Multiples by Practice Type
Veterinary practice valuations in APAC vary significantly by clinic type, geography, and scale:
| Practice Type | EBITDA Multiple | Key Value Drivers |
|---|---|---|
| Solo vet clinic (1 vet) | 5–7× | Client base loyalty, real estate ownership, location |
| Multi-vet GP practice (2–5 vets) | 7–10× | Multi-practitioner depth, structured clinical governance |
| Specialist referral hospital | 8–12× | Specialist scarcity, revenue per consult, referral relationships |
| 24-hour emergency facility | 9–13× | Extended hours licence, referral network role, revenue diversification |
| Mixed large and small animal | 6–9× | Revenue diversification, rural or semi-rural premium for geography |
| Dental and specialist GP combo | 7–10× | Service breadth, recall revenue from dental, client retention |
Australia is the most developed APAC vet consolidation market. Multiples here are at the top of the range for high-quality group practices. Singapore sees premium multiples for specialist and 24-hour facilities given the high pet spend per household and shortage of veterinary capacity. Japan and South Korea are earlier-stage consolidation markets with growing strategic interest. Southeast Asian markets (Thailand, Malaysia, Indonesia) have lower established multiples but growing buyer appetite from regional groups.
According to Bain & Company’s 2026 Global M&A Report, essential services M&A — including healthcare and veterinary — has sustained strong demand despite broader M&A market softness, driven by PE focus on recession-resistant cashflows and demographic tailwinds. Deloitte’s 2025 Life Sciences and Health Care M&A report identifies veterinary and animal health as one of the fastest-growing sub-sectors within the broader healthcare M&A universe, with deal volume increasing each year since 2020 in APAC markets.
The Veterinary PE Roll-Up Model
Understanding the PE buyer’s investment thesis is essential for positioning your practice in a sale. PE-backed consolidators in the vet sector apply a consistent playbook:
Platform acquisitions — a foundational practice with $1M+ EBITDA becomes the platform. The PE buyer pays a premium for the platform (8–12× EBITDA) and subsequently acquires “bolt-on” practices at lower multiples (5–8× EBITDA), which are then consolidated onto the platform infrastructure.
Revenue synergies — shared purchasing, referral integration, specialist deployment across sites, and shared marketing. Buyers pay for practices with a large, loyal, geographically concentrated client base that benefits from shared specialist services.
Cost consolidation — back-office centralisation (billing, HR, compliance), shared purchasing of pharmaceuticals and consumables, and shared technology platforms (practice management software, digital radiology, laboratory). Practices with already-modern systems attract lower integration discounts.
Multiple arbitrage — PE buyers acquire at 5–9× EBITDA in bolt-on acquisitions, and exit the consolidated group at 10–14× EBITDA in a trade sale or secondary buyout. This arbitrage justifies paying above-market prices for foundational platform assets.
Understanding where your practice fits this model — as a platform acquisition candidate or a bolt-on — shapes valuation expectations and negotiation strategy.
What Veterinary Buyers Examine in Due Diligence
Due diligence in veterinary practice M&A covers specific areas that general business buyers may not examine with the same intensity:
Practitioner dependency and succession. What proportion of the practice’s billings and client relationships are attributable to the selling vet? If 70%+ of EBITDA is attributable to one practitioner, buyers price a significant discount and structure retention — earn-outs, employment agreements, or purchase price holdbacks contingent on revenue continuity. Multi-vet practices with documented transition plans trade at premium multiples.
Clinical staffing. Vet nurse and technician retention is a due diligence issue. High turnover in clinical support staff increases training costs and affects service quality. Buyers assess average tenure, pay versus market, and whether staff relationships follow the owner or the practice systems.
Practice management data quality. Revenue by service line (consults, pharmacy, surgery, dental, diagnostics), active client count, client retention rate, and vaccination recall rate must be extractable from your practice management system (Ezyvet, VetlinkSQL, RxWorks, Provet Cloud). Incomplete or inconsistent data records extend due diligence and give buyers room to renegotiate.
Pharmaceutical and controlled substance compliance. DEA and Schedule 4/8 drug registers (Australia), pharmacy board compliance (Singapore), and controlled substance logs are examined thoroughly. Discrepancies or missing records create regulatory risk for buyers and frequently delay or reprice transactions.
Real estate. Ownership versus lease, lease terms, rent-to-EBITDA ratio, and real estate optionality (sale and leaseback as part of the transaction). Practices in owned premises have more transaction structure flexibility; practices in lease-only premises must demonstrate lease security and landlord cooperativeness with assignment.
“The practices that achieve the highest multiples in APAC are not necessarily the highest-revenue ones — they’re the ones with documented systems and multi-vet depth that give buyers confidence the revenue doesn’t leave with the founder,” says Daniel Bae, Founder and CEO of Amafi (US$30B+ in transaction experience). “Every year of preparation you invest before going to market translates directly into a better multiple and a shorter due diligence process.”
How to Run a Confidential Veterinary Practice Sale
Confidentiality is critical in veterinary M&A. Clients who learn the practice is for sale may seek alternative providers. Staff who hear about a sale may begin exploring their own options. Suppliers and pharmaceutical reps may adjust terms or share information in the market.
Blind teaser. Initial buyer outreach uses a blind profile — practice type, geography, revenue range, EBITDA, and the key value drivers — without disclosing the practice name. Qualified buyers sign NDAs before the name and any client, financial, or staff data is shared.
Phased information release. Management accounts and headline financials are shared post-NDA. Detailed financial and operational data (patient records, staff details, supplier contracts) are released only to buyers in advanced discussions.
Buyer qualification gating. Not all buyers who express interest should receive information. Qualifying questions — track record of vet acquisitions, funding structure, geographic focus, typical EBITDA target — filter out non-serious or non-credentialed buyers before information sharing begins.
Advisor or platform intermediary. A licensed M&A advisor or AI-matched platform manages initial contact so your identity is never disclosed until you control the process. Amafi’s confidential marketplace matches practice owners with qualified vet buyers — PE consolidators and corporate groups with registered acquisition criteria — without any public listing. You approve every buyer before any information is shared.
Preparing Your Practice for Sale
The 12–24 months before initiating a sale process are the highest-leverage period for improving sale outcomes:
Reduce practitioner dependency. Hire and develop associate vets who build their own client relationships within the practice. Buyers pay for systems, not for one person. Even one additional associate reduces dependency risk significantly.
Clean up data. Ensure your practice management system has complete, consistent records: active client count, visit frequency, vaccination recall data, revenue by service line, and controlled substance logs. Run a data quality audit 12 months before sale so discrepancies can be corrected rather than discovered in due diligence.
Document systems and processes. Clinical protocols, staff training materials, supplier agreements, pharmaceutical ordering systems, and client communication workflows should be documented. Buyers price documented systems higher than undocumented institutional knowledge.
Understand your real estate position. If you rent, review your lease for assignment provisions, remaining term, and market rent benchmarking. If you own, understand the value of the real estate independent of the business and whether a sale and leaseback would maximise total value.
The Sale Process Step by Step
A typical APAC veterinary practice sale follows six phases:
- Preparation (3–6 months): Organisational due diligence, financials (3 years P&L, balance sheet, tax returns), EBITDA normalisation, and CIM/blind teaser preparation.
- Buyer identification (2–4 weeks): Identify PE consolidators, corporate groups, and strategic buyers with a matching acquisition mandate. Amafi’s confidential matching surfaces qualified buyers before any disclosure.
- Initial outreach and NDA (2–4 weeks): Blind teaser distributed; interested buyers sign NDAs; practice name and headline financials shared.
- Management presentations and indicative offers (4–8 weeks): Site visits, management presentations, and indicative offer letters with valuation range and proposed structure.
- Exclusivity and due diligence (6–10 weeks): Selected buyer enters exclusivity; detailed due diligence on financials, clinical data, staff, real estate, and regulatory compliance.
- Documentation and registration transfer (4–8 weeks): Share purchase or asset purchase agreement; veterinary board registration transfers; DEA/pharmacy registration changes; completion.
Related Guides
- How to sell a medical practice — parallel process for medical and dental practices, including specialist and GP guidance
- How to sell a healthcare business — broader APAC healthcare M&A buyer universe and process overview
- M&A process guide — full sell-side process from preparation to completion
Related Guide
For the broader framework behind this topic, see Amafi’s M&A process guide.
